Obsessive-Compulsive Symptoms in Schizophrenia: an Up-To-Date Review of Literature

  • Chloé Tezenas du Montcel
  • Antoine Pelissolo
  • Franck Schürhoff
  • Baptiste PignonEmail author
Anxiety Disorders (A Pelissolo, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Anxiety Disorders


Purpose of Review

This review will aim to summarize the current body of epidemiological, clinical and therapeutic knowledge concerning specific co-occurrence of obsessive-compulsive symptoms (OCSs) and schizophrenia spectrum disorder.

Recent Findings

Almost 30% of the patients with schizophrenia display OCS, and three main contexts of emergence are identified: prodromal symptoms of schizophrenia, co-occurrence of OCS and schizophrenia and antipsychotics-induced OCS. Recent clinical studies show that patients with SZ and OCS have more severe psychotic and depressive symptoms, higher suicidality and lower social functioning. A recent cognitive investigation found that OCS and delusions share specific metacognitive profiles, particularly through a heightened need to control thoughts. Finally, a recent cross-sectional study of clozapine-induced OCS found a dose-response relationship between clozapine and OCS.


OCS appeared reliably as linked to poorer outcomes among patients with schizophrenia. However, the specific clinical value of OCS among other prodromal symptoms of schizophrenia remains unknown.


Schizophrenia Obsessive-compulsive symptoms Obsessive-compulsive disorder Schizo-obsessive disorder Ultra-high risk (UHR) of psychosis Antipsychotics 


Compliance with Ethical Standards

Conflict of Interest

Chloé Tezenas du Montcel, Franck Schürhoff, and Baptiste Pignon each declare no potential conflicts of interest.

Antoine Pelissolo is a section editor for Current Psychiatry Reports.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Kelly JR, Clarke G, Cryan JF, Dinan TG. Dimensional thinking in psychiatry in the era of the research domain criteria (RDoC). Ir J Psychol Med. 2018;35:89–94.CrossRefGoogle Scholar
  2. 2.
    Leboyer M, Schurhoff F. Searching across diagnostic boundaries. Schizophr Bull. 2014;40:946–8.CrossRefGoogle Scholar
  3. 3.
    Westphal K. Über Zwangsvorstellungen. Archiv fur Psychiatr und Nervenkr. 1878;8:734–750.Google Scholar
  4. 4.
    Bleuler M, Bleuler R. Dementia praecox oder die Gruppe der Schizophrenien: Eugen Bleuler. Br J Psychiatry. 1986;149:661–4.CrossRefGoogle Scholar
  5. 5.
    Janet P, Raymond F. Les obsessions et la psychasténie. Vol. 2. Paris: Felix Alcan; 1903.Google Scholar
  6. 6.
    Attademo L, Bernardini F, Paolini E, Quartesan R. History and conceptual problems of the relationship between obsessions and hallucinations. Harv Rev Psychiatry. 2015;23:19–27.CrossRefGoogle Scholar
  7. 7.
    Achim AM, Maziade M, Raymond E, Olivier D, Mérette C, Roy M-A. How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull. 2011;37:811–21.CrossRefGoogle Scholar
  8. 8.
    Fontenelle LF, Mendlowicz MV, Versiani M. The descriptive epidemiology of obsessive-compulsive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry. 2006;30:327–37.CrossRefGoogle Scholar
  9. 9.
    Swets M, Dekker J, van Emmerik-van Oortmerssen K, Smid GE, Smit F, de Haan L, et al. The obsessive compulsive spectrum in schizophrenia, a meta-analysis and meta-regression exploring prevalence rates. Schizophr Res. 2014;152:458–68.CrossRefGoogle Scholar
  10. 10.
    Attademo L, De Giorgio G, Quartesan R, Moretti P. Schizophrenia and obsessive-compulsive disorder: from comorbidity to schizo-obsessive disorder. Riv Psichiatr. 2012;47:106–15.PubMedGoogle Scholar
  11. 11.
    Bottas A, Cooke RG, Richter MA. Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia: is there evidence for a schizo-obsessive subtype of schizophrenia? J Psychiatry Neurosci JPN. 2005;30:187–93.PubMedGoogle Scholar
  12. 12.
    Poyurovsky M, Weizman A, Weizman R. Obsessive-compulsive disorder in schizophrenia. CNS Drugs. 2004;18:989–1010.CrossRefGoogle Scholar
  13. 13.
    Cederlöf M, Lichtenstein P, Larsson H, Boman M, Rück C, Landén M, et al. Obsessive-compulsive disorder, psychosis, and bipolarity: a longitudinal cohort and multigenerational family study. Schizophr Bull. 2015;41:1076–83.CrossRefGoogle Scholar
  14. 14.
    Van Dael F, van Os J, de Graaf R, ten Have M, Krabbendam L, Myin-Germeys I. Can obsessions drive you mad? Longitudinal evidence that obsessive-compulsive symptoms worsen the outcome of early psychotic experiences. Acta Psychiatr Scand. 2011;123:136–46.CrossRefGoogle Scholar
  15. 15.
    Meier SM, Petersen L, Pedersen MG, Arendt MCB, Nielsen PR, Mattheisen M, et al. Obsessive-compulsive disorder as a risk factor for schizophrenia: a nationwide study. JAMA Psychiatry. 2014;71:1215–21.CrossRefGoogle Scholar
  16. 16.
    Nelson B, Yuen K, Yung AR. Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Schizophr Res. 2011;125:62–8.CrossRefGoogle Scholar
  17. 17.
    Fusar-Poli P, Cappucciati M, Borgwardt S, Woods SW, Addington J, Nelson B, et al. Heterogeneity of psychosis risk within individuals at clinical high risk: a meta-analytical stratification. JAMA Psychiatry. 2016;73:113–20.CrossRefGoogle Scholar
  18. 18.
    Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell’Olio M, et al. Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust N Z J Psychiatry. 2005;39:964–71.CrossRefGoogle Scholar
  19. 19.
    Fontenelle LF, Lin A, Pantelis C, Wood SJ, Nelson B, Yung AR. A longitudinal study of obsessive-compulsive disorder in individuals at ultra-high risk for psychosis. J Psychiatr Res. 2011;45:1140–5.CrossRefGoogle Scholar
  20. 20.
    Łucka I, Fryze M, Cebella A, Staszewska E. Prodromal symptoms of schizophrenics syndrome in children and adolescent. Psychiatr Pol. 2002;36:283–6.PubMedGoogle Scholar
  21. 21.
    Poyurovsky M, Zohar J, Glick I, Koran LM, Weizman R, Tandon R, et al. Obsessive-compulsive symptoms in schizophrenia: implications for future psychiatric classifications. Compr Psychiatry. 2012;53:480–3.CrossRefGoogle Scholar
  22. 22.
    Niendam TA, Berzak J, Cannon TD, Bearden CE. Obsessive compulsive symptoms in the psychosis prodrome: correlates of clinical and functional outcome. Schizophr Res. 2009;108:170–5.CrossRefGoogle Scholar
  23. 23.
    de Haan L, Sterk B, Wouters L, Linszen DH. The 5-year course of obsessive-compulsive symptoms and obsessive-compulsive disorder in first-episode schizophrenia and related disorders. Schizophr Bull. 2013;39:151–60.CrossRefGoogle Scholar
  24. 24.
    Hagen K, Hansen B, Joa I, Larsen TK. Prevalence and clinical characteristics of patients with obsessive-compulsive disorder in first-episode psychosis. BMC Psychiatry. 2013;13:156.CrossRefGoogle Scholar
  25. 25.
    Poyurovsky M, Faragian S, Kleinman-Balush V, Pashinian A, Kurs R, Fuchs C. Awareness of illness and insight into obsessive-compulsive symptoms in schizophrenia patients with obsessive-compulsive disorder. J Nerv Ment Dis. 2007;195:765–8.CrossRefGoogle Scholar
  26. 26.
    Jacob ML, Larson MJ, Storch EA. Insight in adults with obsessive-compulsive disorder. Compr Psychiatry. 2014;55:896–903.CrossRefGoogle Scholar
  27. 27.
    Cherian AV, Narayanaswamy JC, Srinivasaraju R, Viswanath B, Math SB, Kandavel T, et al. Does insight have specific correlation with symptom dimensions in OCD? J Affect Disord. 2012;138:352–9.CrossRefGoogle Scholar
  28. 28.
    Catapano F, Perris F, Fabrazzo M, Cioffi V, Giacco D, De Santis V, et al. Obsessive-compulsive disorder with poor insight: a three-year prospective study. Prog Neuro-Psychopharmacol Biol Psychiatry. 2010;34:323–30.CrossRefGoogle Scholar
  29. 29.
    Fontenelle JM, Harrison BJ, Santana L, Conceição do Rosário M, Versiani M, Fontenelle LF. Correlates of insight into different symptom dimensions in obsessive-compulsive disorder. Ann Clin Psychiatry. 2013;25:11–6.PubMedGoogle Scholar
  30. 30.
    Oulis P, Konstantakopoulos G, Lykouras L, Michalopoulou PG. Differential diagnosis of obsessive-compulsive symptoms from delusions in schizophrenia: a phenomenological approach. World J Psychiatry. 2013;3:50–6.CrossRefGoogle Scholar
  31. 31.
    Fineberg NA, Gale TM. Evidence-based pharmacotherapy of obsessive-compulsive disorder. Int J Neuropsychopharmacol. 2005;8:107–29.CrossRefGoogle Scholar
  32. 32.
    Cunill R, Castells X, Simeon D. Relationships between obsessive-compulsive symptomatology and severity of psychosis in schizophrenia: a systematic review and meta-analysis. J Clin Psychiatry. 2009;70:70–82.CrossRefGoogle Scholar
  33. 33.
    • Baytunca B, Kalyoncu T, Ozel I, Erermiş S, Kayahan B, Öngur D. Early onset schizophrenia associated with obsessive-compulsive disorder: clinical features and correlates. Clin Neuropharmacol. 2017;40:243–5. In a retrospective chart review of 29 patients with early onset SZ (10 with OCS/SZ, 19 SZ), patients suffering from SZ/OCS received significantly higher doses of antipsychotics during the first episode and at assessment (no sociodemographic differences, similar duration of illnesses and had comparable severity scores on PANSS). CrossRefGoogle Scholar
  34. 34.
    • Tonna M, Ottoni R, Paglia F, Monici A, Ossola P, DE Panfilis C, et al. Obsessive-compulsive symptoms in schizophrenia and in obsessive-compulsive disorder: differences and similarities. J Psychiatr Pract. 2016;22:111–6. In this clinical study of the content of obsessions and compulsions in 66 patients suffering from SZ/OCD (n= 35) or OCD (n=31), OCD patients had a greater level of distress for obsession and compulsion, and obsessive ideas were more aggressive, contamination-related, sexual and somatic obsession in the OCD group than in the SZ group. Patients had similar severity levels, and no association were found between OCS severity and PANSS scores, but delusional symptoms were positively associated with the presence of washing compulsion and hoarding obsession. CrossRefGoogle Scholar
  35. 35.
    Szmulewicz AG, Smith JM, Valerio MP. Suicidality in clozapine-treated patients with schizophrenia: role of obsessive-compulsive symptoms. Psychiatry Res. 2015;230:50–5.CrossRefGoogle Scholar
  36. 36.
    Addington D, Addington J, Maticka-Tyndale E, Joyce J. Reliability and validity of a depression rating scale for schizophrenics. Schizophr Res. 1992;6:201–8.CrossRefGoogle Scholar
  37. 37.
    Fenton WS, McGlashan TH. The prognostic significance of obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry. 1986;143:437–41.CrossRefGoogle Scholar
  38. 38.
    Hur J-W, Shin NY, Jang JH, Shim G, Park HY, Hwang JY, et al. Clinical and neurocognitive profiles of subjects at high risk for psychosis with and without obsessive-compulsive symptoms. Aust N Z J Psychiatry. 2012;46:161–9.CrossRefGoogle Scholar
  39. 39.
    Marder SR, Fenton W. Measurement and treatment research to improve cognition in schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia. Schizophr Res. 2004;72:5–9.CrossRefGoogle Scholar
  40. 40.
    Bulzacka E, Boyer L, Schürhoff F, Godin O, Berna F, Brunel L, et al. Chronic peripheral inflammation is associated with cognitive impairment in schizophrenia: results from the multicentric FACE-SZ dataset. Schizophr Bull. 2016;42:1290–302.CrossRefGoogle Scholar
  41. 41.
    Roux P, Urbach M, Fonteneau S, Berna F, Brunel L, Capdevielle D, et al. Psychiatric disability as mediator of the neurocognition-functioning link in schizophrenia spectrum disorders: SEM analysis using the evaluation of cognitive processes involved in disability in schizophrenia (ECPDS) scale. Schizophr Res. 2018;201:196–203.CrossRefGoogle Scholar
  42. 42.
    Michalopoulou PG, Konstantakopoulos G, Typaldou M, Papageorgiou C, Christodoulou GN, Lykouras L, et al. Can cognitive deficits differentiate between schizophrenia with and without obsessive-compulsive symptoms? Compr Psychiatry. 2014;55:1015–21.CrossRefGoogle Scholar
  43. 43.
    •• Schirmbeck F, Rausch F, Englisch S, Eifler S, Esslinger C, Meyer-Lindenberg A, et al. Stable cognitive deficits in schizophrenia patients with comorbid obsessive-compulsive symptoms: a 12-month longitudinal study. Schizophr Bull. 2013;39:1261–71. In this 6-months longitudinal study of SZ patients (N = 56) and their unaffected siblings (N = 49), higher severity of positive, negative, and depressive symptoms was positively associated with higher concurrent OCS severity across subject and significantly predicted OCS severity 4 weeks later and vice-versa. CrossRefGoogle Scholar
  44. 44.
    Pallanti S, Castellini G, Chamberlain SR, Quercioli L, Zaccara G, Fineberg NA. Cognitive event-related potentials differentiate schizophrenia with obsessive-compulsive disorder (schizo-OCD) from OCD and schizophrenia without OC symptoms. Psychiatry Res. 2009;170:52–60.CrossRefGoogle Scholar
  45. 45.
    •• Hagen K, Solem S, Opstad HB, Hansen B, Hagen R. The role of metacognition and obsessive-compulsive symptoms in psychosis: an analogue study. BMC Psychiatry. 2017;17:233. Among a non-clinical sample (N = 194), OCS were moderately-strongly correlated with psychotic symptoms (paranoia and hallucinations). OCS and metacognitive dysfunction both showed a significant influence and accounted for important variance on the levels of paranoid ideation and hallucinations. CrossRefGoogle Scholar
  46. 46.
    Morrison AP, Haddock G, Tarrier N. Intrusive thoughts and auditory hallucinations: a cognitive approach. Behav Cogn Psychother. 1995;23:265–80.CrossRefGoogle Scholar
  47. 47.
    Moritz S, Peters MJV, Larøi F, Lincoln TM. Metacognitive beliefs in obsessive-compulsive patients: a comparison with healthy and schizophrenia participants. Cogn Neuropsychiatry. 2010;15:531–48.CrossRefGoogle Scholar
  48. 48.
    de Haan L, Linszen DH, Gorsira R. Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders. J Clin Psychiatry 1999;60:364–365.CrossRefGoogle Scholar
  49. 49.
    Baker RW, Chengappa KN, Baird JW, Steingard S, Christ MA, Schooler NR. Emergence of obsessive compulsive symptoms during treatment with clozapine. J Clin Psychiatry. 1992;53:439–42.PubMedGoogle Scholar
  50. 50.
    Grillault Laroche D, Gaillard A. Induced obsessive compulsive symptoms (OCS) in schizophrenia patients under atypical 2 antipsychotics (AAPs): review and hypotheses. Psychiatry Res. 2016;246:119–28.CrossRefGoogle Scholar
  51. 51.
    Fonseka TM, Richter MA, Müller DJ. Second generation antipsychotic-induced obsessive-compulsive symptoms in schizophrenia: a review of the experimental literature. Curr Psychiatry Rep. 2014;16:510.CrossRefGoogle Scholar
  52. 52.
    Zink M. Comorbid obsessive-compulsive symptoms in schizophrenia: insight into pathomechanisms facilitates treatment. Adv Med. 2014;2014:317980.CrossRefGoogle Scholar
  53. 53.
    Schirmbeck F, Konijn M, Hoetjes V, Zink M, de Haan L. For genetic risk and outcome of psychosis (GROUP). Obsessive-compulsive symptoms in psychotic disorders: longitudinal associations of symptom clusters on between- and within-subject levels. Eur Arch Psychiatry Clin Neurosci. 2018.Google Scholar
  54. 54.
    Lin S-K, Su S-F, Pan C-H. Higher plasma drug concentration in clozapine-treated schizophrenic patients with side effects of obsessive/compulsive symptoms. Ther Drug Monit. 2006;28:303–7.CrossRefGoogle Scholar
  55. 55.
    Meltzer HY. Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology. 1989;99(Suppl):S18–27.CrossRefGoogle Scholar
  56. 56.
    Englisch S, Esslinger C, Inta D, Weinbrenner A, Peus V, Gutschalk A, et al. Clozapine-induced obsessive-compulsive syndromes improve in combination with aripiprazole. Clin Neuropharmacol. 2009;32:227–9.CrossRefGoogle Scholar
  57. 57.
    Englisch S, Zink M. Combined antipsychotic treatment involving clozapine and aripiprazole. Prog Neuro-Psychopharmacol Biol Psychiatry. 2008;32:1386–92.CrossRefGoogle Scholar
  58. 58.
    •• Fernandez-Egea E, Worbe Y, Bernardo M, Robbins TW. Distinct risk factors for obsessive and compulsive symptoms in chronic schizophrenia. Psychol Med. 2018;48:2668–75. In this study of risk factor of clozapine-induced OCS in a sample of clozapine-treated SZ patients (N = 118), 47 % of the sample reached threshold criteria for OCD and were on anti-OCD medication. Length of clozapine treatment was correlated with checking severity and authors showed a direct correlation between OCS and clozapine plasma levels. Patients on polypharmacy had higher OCS scores and higher OCD prevalence. CrossRefGoogle Scholar
  59. 59.
    Schirmbeck F, Zink M. Comorbid obsessive-compulsive symptoms in schizophrenia: contributions of pharmacological and genetic factors. Front Pharmacol. 2013;4:99.CrossRefGoogle Scholar
  60. 60.
    Schirmbeck F, Esslinger C, Rausch F, Englisch S, Meyer-Lindenberg A, Zink M. Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia. Psychol Med. 2011;41:2361–73.CrossRefGoogle Scholar
  61. 61.
    Stryjer R, Dambinsky Y, Timinsky I, Green T, Kotler M, Weizman A, et al. Escitalopram in the treatment of patients with schizophrenia and obsessive-compulsive disorder: an open-label, prospective study. Int Clin Psychopharmacol. 2013;28:96–8.CrossRefGoogle Scholar
  62. 62.
    Poyurovsky M, Faragian S, Shabeta A, Kosov A. Comparison of clinical characteristics, co-morbidity and pharmacotherapy in adolescent schizophrenia patients with and without obsessive-compulsive disorder. Psychiatry Res. 2008;159:133–9.CrossRefGoogle Scholar
  63. 63.
    Sugarman MA, Kirsch I, Huppert JD. Obsessive-compulsive disorder has a reduced placebo (and antidepressant) response compared to other anxiety disorders: a meta-analysis. J Affect Disord. 2017;218:217–26.CrossRefGoogle Scholar
  64. 64.
    Denys D, Zohar J, Westenberg HG. The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence. J Clin Psychiatry. 2004;65(Suppl 14):11–7.PubMedGoogle Scholar
  65. 65.
    Pignon B, Tezenas du Montcel C, Carton L, Pelissolo A. The place of antipsychotics in the therapy of anxiety disorders and obsessive-compulsive disorders. Curr Psychiatry Rep. 2017;19:103.CrossRefGoogle Scholar
  66. 66.
    van Nimwegen L, de Haan L, van Beveren N, Laan W, van den Brink W, Linszen D. Obsessive-compulsive symptoms in a randomized, double-blind study with olanzapine or risperidone in young patients with early psychosis. J Clin Psychopharmacol. 2008;28:214–8.CrossRefGoogle Scholar
  67. 67.
    Temmingh H, Stein DJ. Anxiety in patients with schizophrenia: epidemiology and management. CNS Drugs. 2015;29:819–32.CrossRefGoogle Scholar
  68. 68.
    McDougle CJ, Goodman WK, Price LH. Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder. J Clin Psychiatry. 1994;55(Suppl):24–31.PubMedGoogle Scholar
  69. 69.
    Matsunaga H, Nagata T, Hayashida K, Ohya K, Kiriike N, Stein DJ. A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder. J Clin Psychiatry. 2009;70:863–8.CrossRefGoogle Scholar
  70. 70.
    Kapur S, Zipursky RB, Remington G. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am J Psychiatry. 1999;156:286–93.PubMedGoogle Scholar
  71. 71.
    Ramasubbu R, Ravindran A, Lapierre Y. Serotonin and dopamine antagonism in obsessive-compulsive disorder: effect of atypical antipsychotic drugs. Pharmacopsychiatry. 2000;33:236–8.CrossRefGoogle Scholar
  72. 72.
    Schirmbeck F, Zink M. Comorbid obsessive-compulsive symptoms in schizophrenia: contributions of pharmacological and genetic factors. Front Pharmacol [Internet] 2013 [cited 2018 Dec 9];4. Available from: Accessed 09 Jun 2019.
  73. 73.
    Villari V, Frieri T, Fagiolini A. Aripiprazole augmentation in clozapine-associated obsessive-compulsive symptoms. J Clin Psychopharmacol. 2011;31:375–6.CrossRefGoogle Scholar
  74. 74.
    Eryılmaz G, Hızlı Sayar G, Ozten E, Gögcegöz Gül I, Karamustafalıoğlu O. Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia. Ann General Psychiatry. 2013;12:40.CrossRefGoogle Scholar
  75. 75.
    Jacobsen FM. Risperidone in the treatment of affective illness and obsessive-compulsive disorder. J Clin Psychiatry. 1995;56:423–9.PubMedGoogle Scholar
  76. 76.
    Hanisch F, Friedemann J, Piro J, Gutmann P. Maintenance electroconvulsive therapy for comorbid pharmacotherapy-refractory obsessive-compulsive and schizoaffective disorder. Eur J Med Res. 2009;14:367–8.CrossRefGoogle Scholar
  77. 77.
    Tundo A, Necci R. Cognitive-behavioural therapy for obsessive-compulsive disorder co-occurring with psychosis: systematic review of evidence. World J Psychiatry. 2016;6:449–55.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Chloé Tezenas du Montcel
    • 1
    • 2
    • 3
  • Antoine Pelissolo
    • 1
    • 2
    • 3
    • 4
  • Franck Schürhoff
    • 1
    • 2
    • 3
    • 4
  • Baptiste Pignon
    • 1
    • 2
    • 3
    • 4
    Email author
  1. 1.AP-HP, DHU PePSYHôpitaux Universitaires Henri-MondorCréteilFrance
  2. 2.Fondation FondaMentalCréteilFrance
  3. 3.UPEC, Faculté de médecineUniversité Paris-EstCréteilFrance
  4. 4.INSERMCréteilFrance

Personalised recommendations